D'Alessandro Nicola, Tramutola Giuseppe, Fasano Giovanni Michele, Gilio Francesco, Iside Giovanni, Izzo Maria Lucia, Loffredo Andrea, Pici Mariano, Pinto Margherita, Tramontano Salvatore, Citro Giuseppe
Ann Ital Chir. 2016;87:214-9.
Definitive hypoparathyrodism (hypo-PTH) represents one of the most dangerous complication after total thyroidectomy. Partial or total lesion or accidental removal of parathyroid glands is an unpredictable adverse event, although real incidence is not well defined, such as management of this deficit. We started a prospective evaluation of patients treated with total thyroidectomy in our centre, to identify incidence of hypo-PTH, symptomatic or not, in relation to incidence of early postoperative hypocalcemia in our experience.
We prospectively evaluated 177 patients treated for benign and malign pathology, measuring calcium before surgery and calcium and PTH at least three months after surgery. Postoperative hypocalcemia was observed in 37.3% of cases. Eight patients (4.5% of cohort) presented low level of PTH, at mean follow-up of 9.1 months. Positive predictive value for postoperative hypocalcemia was 12.1%, while negative predictive was 95.4%; confirming high sensitivity (100%) and low specificity (65.4%) for detecting hypo-PTH.
All patients with late hypo-PTH presented hypocalcemia on early analysis, while no case with normal postoperative calcemia accounted with hypo-PTH: this may indicate calcemia as valid prognostic factor of good gland production, when is in the range. Moreover, isolated analysis is too limited to determine real predictability.
Technical standardization represents the best method for prevention of hypo-PTH. Early hypocalcemia is a prognostic factor, even with a low specificity, of deficit of PTH-production. This observation must be related to other known prognostic factors. Postoperative normal calcemia should be a positive prognostic factor of an acceptable PTHfunction, supported by large cohorts.
Hypocalcemia, Parathormone, Thyroidectomy.
永久性甲状旁腺功能减退(甲状旁腺功能减退症)是全甲状腺切除术后最危险的并发症之一。甲状旁腺部分或全部损伤或意外切除是一种不可预测的不良事件,尽管其实际发生率以及对此种功能缺陷的处理方式尚无明确界定。我们对本中心接受全甲状腺切除术的患者展开了一项前瞻性评估,以根据我们的经验确定甲状旁腺功能减退症(无论有无症状)的发生率与术后早期低钙血症发生率之间的关系。
我们对177例因良性和恶性病变接受治疗的患者进行了前瞻性评估,在术前测量血钙水平,并在术后至少三个月测量血钙和甲状旁腺激素水平。37.3%的病例观察到术后低钙血症。8例患者(占队列的4.5%)甲状旁腺激素水平较低,平均随访时间为9.1个月。术后低钙血症的阳性预测值为12.1%,阴性预测值为95.4%;证实检测甲状旁腺功能减退症的敏感性高(100%)而特异性低(65.4%)。
所有晚期甲状旁腺功能减退症患者在早期分析时均出现低钙血症,而术后血钙正常的病例均未出现甲状旁腺功能减退症:这可能表明血钙处于正常范围时是甲状旁腺良好分泌功能的有效预后指标。此外,单独分析过于有限,无法确定真正的可预测性。
技术标准化是预防甲状旁腺功能减退症的最佳方法。早期低钙血症是甲状旁腺激素分泌不足的一个预后因素,尽管特异性较低。这一观察结果必须与其他已知的预后因素相关联。术后血钙正常应是可接受的甲状旁腺功能的一个阳性预后因素,这一观点得到了大量队列研究的支持。
低钙血症;甲状旁腺激素;甲状腺切除术